Do I need to pay attention to liver function tests while taking sorafenib?

Sorafenib is a multi-target tyrosine kinase inhibitor commonly used to treat various types of cancer, such as liver cancer, kidney cancer and thyroid cancer. It reduces tumor growth and spread by inhibiting the growth of tumor cells and inhibiting tumor angiogenesis. Although sorafenib has a significant effect in cancer treatment, it may have certain effects on the liver. Therefore, special attention needs to be paid to monitoring liver function when taking sorafenib.

Abnormal liver function is a common side effect during sorafenib treatment. Sorafenib may cause an increase in liver enzyme levels, manifested as markers of liver cell damage, such as increases in alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) in the blood. The occurrence of liver function abnormalities may affect a patient's liver health and in some cases lead to liver damage. Therefore, it is necessary to conduct regular liver function tests during the use of sorafenib.

Because sorafenib may cause liver function damage, especially in patients with underlying liver diseases (such as cirrhosis or hepatitis), regular examination of liver function is particularly important. By monitoring liver enzyme levels, doctors can detect adverse reactions in the liver in time and take appropriate treatment measures. If liver function is significantly abnormal, your doctor may recommend reducing the dose of medication, suspending treatment, or changing treatment regimens to reduce the risk of liver damage.

Patients with liver cancer, especially those with pre-existing cirrhosis or chronic liver disease, need to be cautious when taking sorafenib. Liver damage may make liver function more fragile in these patients, thereby increasing the risk of adverse drug reactions. Therefore, a comprehensive assessment of liver function before treatment and close monitoring of changes in liver function during treatment can help doctors adjust treatment strategies in a timely manner to ensure patient safety.

Reference materials:https://www.nexavar.com/